Health Letter, May 2021
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
Spironolactone tablets, 25 mg, packaged in 30-, 60- and 90-count bottles. Manufactured by: Frontida BioPharm, Inc. Lot #: 148969, exp. date: 7/31/2022; Lot #: 148791, exp. date: 7/31/2022; Lot #: 148991, exp. date: 7/31/2022.
Telmisartan tablets, 20 mg, 30-count bottles. Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division). Lot #: 1905005661, exp. date: March 2022.
Guanfacine extended-release tablets, 2 mg, 100-count bottles. Manufactured by: Apotex Inc. Lot #: RX1662, RX1663 or RX1664, exp. date: 11/2022
Neomycin sulfate tablets, 500 mg, 10×10 unit dose, 100 tablets. Manufactured for: X-GEN Phamaceuticals, Inc. Lot #: CFMBX, exp. date: 9/2022.
Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles. Packaged and distributed by: Direct Rx. Lot#: 28DE2002, exp. date: 10/31/22.
Omeprazole delayed-release capsules, 20 mg, 1,000-count bottles. Distributed by: Breckenridge Pharmaceutical, Inc., and manufactured by: Tow Pharmaceutical Europe, S.L., or packaged by GSMS Incorporated. Lot #: 191659, exp. date: 05/2021; Lot #: GS029673, exp. date: 5/2021.
Spironolactone tablets, 50 mg, packaged in 30-count bottles. Manufactured by: Frontida BioPharm, Inc. Lot #: 148992, exp. date: 5/31/2022.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.